What does the manufacturer of Lufenuron (Novartis) say about its safety?
“Program® (Lufenuron) has undergone numerous safety trials to test its margin of safety at various doses. In addition, it has been available worldwide in over 30 countries with no adverse reactions found. The reason that Program® (Lufenuron) is so safe is that it is biologically inert in mammals – meaning it is not broken down by the liver or kidneys. As such it is safe in all mammals. Program® (Lufenuron) has been tested at hundreds of times the label dose with absolutely no difficulties of any kind. Program® (Lufenuron) exhibits no drug interactions, therefore it has no ill effect on older subjects, or subjects with liver or renal problems, regardless of any medications those subjects may be on for their medical conditions. It does not affect diabetics or subjects on antibiotics. There is no bio-accumulation so there is no chance of Program® (Lufenuron) building up and causing a problem in the long term. It is standard practice for all drugs to be tested for an ‘LD50.’ This is the re
